Company · CIK 0001310094
ACCENTIA BIOPHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
FL
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AACCENTIA BIOPHARMACEUTICALS INC0001457716-15-000025 · 162.0 KBSEC(opens sec.gov)
- SC 13GACCENTIA BIOPHARMACEUTICALS INC0001193125-15-039232 · 33.4 KBSEC(opens sec.gov)
- 4Insider trades0001214659-13-006340 · 5.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-13-003905 · 44.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-13-001282 · 27.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001214659-13-000986 · 27.7 KBSEC(opens sec.gov)
- 10-QQuarterly update0001214659-13-000877 · 1.2 MBSEC(opens sec.gov)
- 10-KAnnual report0001193125-12-514944 · 13.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-12-479724 · 13.5 KBSEC(opens sec.gov)
- 4Insider trades0001181431-12-055667 · 5.4 KBSEC(opens sec.gov)
Insiders
- Calder Douglas WVP Strategic Plan/Cap Markets
- CHAPMAN CHRISTOPHER CDirector
- DUBINSKY JOHN PDirector
- DUFFEY SAMUEL SCEO/PRESIDENT/GENERAL COUNSEL
- Hasara Garrison J.Acting Chief Financial Officer
- HOPKINS CAPITAL GROUP LLC10% Owner
- KING EDMUNDDirector
- ODONNELL FRANCIS E JRDirector
- Pearce Alan MDirector, Chief Financial Officer
- Poole WilliamDirector
Tickers
No tickers on record.
Addresses
business
324 SOUTH HYDE PARK AVE SUITE 350
TAMPA, FL, 33606
mailing
324 SOUTH HYDE PARK AVE SUITE 350
TAMPA, FL, 33606
Same industry